BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

141 related articles for article (PubMed ID: 20447811)

  • 1. Selective binding of small molecules to DNA: application and perspectives.
    Wang B; Tan J; Zhu L
    Colloids Surf B Biointerfaces; 2010 Aug; 79(1):1-4. PubMed ID: 20447811
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Modulation of transcription factor--DNA interactions by anticancer drugs.
    Broggini M; D'Incalci M
    Anticancer Drug Des; 1994 Aug; 9(4):373-87. PubMed ID: 7916903
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Heterogeneity in the actions of drugs that bind in the DNA minor groove.
    Albert FG; Eckdahl TT; Fitzgerald DJ; Anderson JN
    Biochemistry; 1999 Aug; 38(31):10135-46. PubMed ID: 10433722
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Drug-DNA sequence-dependent interactions analysed by electric linear dichroism.
    Bailly C; Hénichart JP; Colson P; Houssier C
    J Mol Recognit; 1992 Dec; 5(4):155-71. PubMed ID: 1339484
    [TBL] [Abstract][Full Text] [Related]  

  • 5. REPSA: combinatorial approach for identifying preferred drug-DNA binding sequences.
    Van Dyke MW
    Methods Mol Biol; 2010; 613():193-205. PubMed ID: 19997885
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Drug-DNA recognition: energetics and implications for design.
    Haq I; Ladbury J
    J Mol Recognit; 2000; 13(4):188-97. PubMed ID: 10931556
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Influence of compound structure on affinity, sequence selectivity, and mode of binding to DNA for unfused aromatic dications related to furamidine.
    Nguyen B; Tardy C; Bailly C; Colson P; Houssier C; Kumar A; Boykin DW; Wilson WD
    Biopolymers; 2002 Apr; 63(5):281-97. PubMed ID: 11877739
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Drug discovery with engineered zinc-finger proteins.
    Jamieson AC; Miller JC; Pabo CO
    Nat Rev Drug Discov; 2003 May; 2(5):361-8. PubMed ID: 12750739
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Drugs targeting protein-protein interactions.
    Chène P
    ChemMedChem; 2006 Apr; 1(4):400-11. PubMed ID: 16892375
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Thermodynamics aspects of interactions between small ligands and DNA].
    Jagiełło K; Dopierała A; Mazerski J
    Postepy Biochem; 2010; 56(3):341-9. PubMed ID: 21117322
    [TBL] [Abstract][Full Text] [Related]  

  • 11. DNA recognition by lexitropsins, minor groove binding agents.
    Lown JW
    J Mol Recognit; 1994 Jun; 7(2):79-88. PubMed ID: 7826677
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Energetics of drug-DNA interactions.
    Chaires JB
    Biopolymers; 1997; 44(3):201-15. PubMed ID: 9591476
    [TBL] [Abstract][Full Text] [Related]  

  • 13. pH-controlled reversible drug binding and release using a cytosine-rich hairpin DNA.
    Xu C; Zhao C; Ren J; Qu X
    Chem Commun (Camb); 2011 Jul; 47(28):8043-5. PubMed ID: 21677978
    [TBL] [Abstract][Full Text] [Related]  

  • 14. An in vitro transcription assay for probing drug-DNA interactions during active transcription of DNA.
    Phillips DR; Crothers DM
    Methods Mol Biol; 1995; 37():89-105. PubMed ID: 7540091
    [No Abstract]   [Full Text] [Related]  

  • 15. Occurrence of DNA sequences specifically recognized by drugs in human promoters.
    Mansilla S; Portugal J
    J Biomol Struct Dyn; 2002 Feb; 19(4):669-79. PubMed ID: 11843628
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The interaction of unfused polyaromatic heterocycles with DNA: intercalation, groove-binding and bleomycin amplification.
    Wilson WD; Tanious FA; Barton HJ; Wydra RL; Jones RL; Boykin DW; Strekowski L
    Anticancer Drug Des; 1990 Feb; 5(1):31-42. PubMed ID: 1690546
    [TBL] [Abstract][Full Text] [Related]  

  • 17. In vitro transcription assay for resolution of drug-DNA interactions at defined DNA sequences.
    Evison BJ; Phillips DR; Cutts SM
    Methods Mol Biol; 2010; 613():207-22. PubMed ID: 19997886
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Drugs for 'protein clouds': targeting intrinsically disordered transcription factors.
    Dunker AK; Uversky VN
    Curr Opin Pharmacol; 2010 Dec; 10(6):782-8. PubMed ID: 20889377
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Non-covalent ligand/DNA interactions: minor groove binding agents.
    Nelson SM; Ferguson LR; Denny WA
    Mutat Res; 2007 Oct; 623(1-2):24-40. PubMed ID: 17507044
    [TBL] [Abstract][Full Text] [Related]  

  • 20. How does the GAL4 transcription factor recognize the appropriate DNA binding sites in vivo?
    Kodadek T
    Cell Mol Biol Res; 1993; 39(4):355-60. PubMed ID: 8312971
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.